Advanced Non Small Cell Lung Cancer Clinical Trials

ReadTheTrial indexes 2 studies for Advanced Non Small Cell Lung Cancer. The most common development stage is Phase 3 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Advanced Non Small Cell Lung Cancer.

Pipeline by Phase

PhaseTrialsDistribution
Phase 3 1
50%
Phase 1 1
50%

Trial Status Breakdown

Trials for Advanced Non Small Cell Lung Cancer

AN INTERVENTIONAL PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS PEMBROLIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER

NCT07222566 · RECRUITING · Phase 3

Phase I Study of Aerosolized Antibiotics and Pembrolizumab in Advanced Non-Small Cell Lung Cancer

NCT05777603 · RECRUITING · Phase 1

Frequently Asked Questions

What clinical trials are available for Advanced Non Small Cell Lung Cancer?

There are 2 clinical trials listed for Advanced Non Small Cell Lung Cancer. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Advanced Non Small Cell Lung Cancer trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Advanced Non Small Cell Lung Cancer trials in?

Current Advanced Non Small Cell Lung Cancer trials are distributed across: Phase 3 (1), Phase 1 (1).

Find More Trials